Z-VRPR-FMK trifluoroacetate salt

Z-VRPR-FMK trifluoroacetate salt is a synthetic peptide-based irreversible inhibitor that specifically targets caspase-6, a cysteine protease involved in the execution phase of apoptosis. As a fluoromethyl ketone (FMK) derivative, it incorporates a reactive warhead that covalently modifies the active site cysteine residue in caspase-6, leading to sustained enzyme inhibition. The peptide sequence VRPR confers selectivity, allowing researchers to dissect the distinct roles of caspase-6 in programmed cell death and related cellular processes. Because of its biochemical specificity and stability, Z-VRPR-FMK trifluoroacetate salt is widely recognized as a valuable tool in apoptosis research and protease activity profiling.

Apoptosis pathway studies: In cellular and molecular biology research, Z-VRPR-FMK trifluoroacetate salt is frequently employed to elucidate the mechanistic details of apoptosis, particularly the role of caspase-6 in the cleavage of nuclear and cytoskeletal substrates. By selectively inhibiting caspase-6 activity, investigators can differentiate between caspase-dependent and independent cell death mechanisms, enabling a more refined understanding of the molecular events underlying programmed cell death. This facilitates the identification of downstream effectors and regulatory checkpoints within apoptosis signaling cascades.

Protease selectivity assays: The compound is instrumental in validating the substrate specificity and selectivity of caspase-6 versus other related caspases, such as caspase-3 and caspase-7. By incorporating Z-VRPR-FMK into in vitro enzymatic assays or cell-based systems, researchers can assess the inhibitor's impact on proteolytic activity and confirm the functional relevance of caspase-6 in various biological contexts. Such selectivity profiling is essential for distinguishing overlapping substrate preferences and for developing more targeted protease inhibitors.

Functional proteomics: Z-VRPR-FMK trifluoroacetate salt is utilized in functional proteomics approaches to map the proteolytic landscape of apoptotic cells. Its irreversible binding to active caspase-6 permits the capture and identification of enzyme-inhibitor complexes, which can be analyzed by mass spectrometry or immunodetection techniques. This enables the characterization of active protease pools and the exploration of dynamic changes in caspase-6 activation during different stages of cell death or in response to specific stimuli.

Drug discovery research: In the context of early-stage drug screening and mechanistic studies, the inhibitor serves as a reference compound for benchmarking novel caspase-6 inhibitors or chemical probes. Its well-characterized mode of action provides a reliable standard for comparative analysis, supporting the evaluation of potency, selectivity, and off-target effects in candidate molecules. This contributes to the rational design and optimization of next-generation protease modulators for research applications.

Cellular signaling investigations: The use of Z-VRPR-FMK trifluoroacetate salt extends to broader studies of cellular signaling networks where caspase-6 plays a modulatory role beyond apoptosis, such as in neurodegeneration, inflammation, and differentiation. By modulating caspase-6 activity in cultured cells or tissue extracts, scientists can explore the enzyme's involvement in non-apoptotic pathways, uncovering novel regulatory functions and potential cross-talk with other proteolytic systems. This enhances the understanding of caspase biology and supports the development of new experimental models for complex cellular processes.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling